The use of carbonic anhydrase inhibitors in treating hypertension ...

[cabate]

The use of carbonic anhydrase inhibitors in treating hypertension has declined. However, they are now used primarily to decrease:
 
  a. elevated blood glucose. c. increased intraocular pressure.
  b. elevated serum uric acid. d. increased potassium levels.

Question 2

A client is prescribed aldactazide. When preparing to teach the client about the medication, the nurse understands that this agent is a:
 
  a. combination loop and thiazide diuretic agent.
  b. the same agent as bumetanide and hydrochlorothiazide (HCTZ).
  c. combination of osmotic and potassium-sparing diuretic.
  d. combination potassium-sparing and thiazide diuretics.

[Cheesycrackers]

Answer to Question 1

ANS: C

Feedback
A Incorrect: These agents are not used to treat hyperglycemia.
B Incorrect: These agents are not used to treat hyperuricemia.
C Correct: They are used primarily in the treatment of glaucoma.
D Incorrect: These agents are not used to treat hyperkalemia.

Answer to Question 2

ANS: D

Feedback
A Incorrect: Aldactazide is not a combination loop and thiazide diuretic.
B Incorrect: Aldactazide is not bumetanide and HCTZ.
C Incorrect: Aldactazide is not a combination osmotic and potassium-sparing diuretic.
D Correct: Aldactazide is a combination of spirolactone and HCTZ.

[cabate]

TY

[Cheesycrackers]

You're welcome